RHUMBLINE ADVISERS - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 112 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2017. The put-call ratio across all filers is 1.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$227,000
+76.0%
49,222
+33.7%
0.00%
Q4 2018$129,000
-49.2%
36,822
+46.3%
0.00%
Q3 2018$254,000
+30.3%
25,165
-6.4%
0.00%
Q2 2018$195,000
+34.5%
26,890
+12.4%
0.00%
Q1 2018$145,000
-39.1%
23,930
-3.1%
0.00%
Q4 2017$238,000
-15.9%
24,705
-22.4%
0.00%
-100.0%
Q3 2017$283,000
-27.8%
31,845
+2.8%
0.00%0.0%
Q2 2017$392,000
+27.7%
30,970
+6.1%
0.00%0.0%
Q1 2017$307,000
+16.3%
29,177
+1.5%
0.00%0.0%
Q4 2016$264,000
-19.3%
28,744
+3.6%
0.00%0.0%
Q3 2016$327,000
-10.2%
27,740
-1.4%
0.00%0.0%
Q2 2016$364,000
-13.3%
28,140
+7.2%
0.00%0.0%
Q1 2016$420,000
-42.4%
26,255
+3.1%
0.00%
-50.0%
Q4 2015$729,000
+9.5%
25,465
+8.8%
0.00%0.0%
Q3 2015$666,000
-21.0%
23,400
-0.3%
0.00%
-33.3%
Q2 2015$843,000
+39.1%
23,462
+125.1%
0.00%
+50.0%
Q1 2015$606,000
+58.2%
10,421
+14.6%
0.00%
+100.0%
Q4 2014$383,000
+10.4%
9,096
+1.7%
0.00%0.0%
Q3 2014$347,000
+25.7%
8,946
+1.4%
0.00%0.0%
Q2 2014$276,000
-3.8%
8,826
+27.2%
0.00%0.0%
Q1 2014$287,0006,9370.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2017
NameSharesValueWeighting ↓
Orbimed Advisors 6,171,440$54,802,0000.52%
Regal Investment Advisors LLC 161,600$1,435,0000.34%
Folger Hill Asset Management LP 396,315$3,519,0000.30%
SCHNEIDER CAPITAL MANAGEMENT CORP 181,900$1,615,0000.29%
Mirae Asset Global Investments Co., Ltd. 1,033,683$9,179,0000.17%
JW Asset Management, LLC 29,409$72,0000.05%
TCI Wealth Advisors, Inc. 9,516$85,0000.04%
GAM Holding AG 83,940$745,0000.03%
Freedom Investment Management, Inc. 63,032$560,0000.03%
Sterling Investment Advisors, Ltd. 5,000$44,0000.03%
View complete list of INSYS THERAPEUTICS INC NEW shareholders